| Related sites for http://www.legalnewswatch.com/ |
| Pilgrim_Holiness_Church Middleburgh, New York. Services, church information, news, pastor, events, photos, prayers, devotional, contact and location. | | Outwoods Includes membership information, event calendar, leadership guidelines, and links page. Based in Minneapolis, Minnesota. | | CDI_Reports Browse through a report by The Center for Defense Information (CDI) on global response, terrorist organizations, targets, homeland defense, and legislations. | | Arsha_Bodha_Center A non-profit center for teachings of Ancient India like Vedanta, Bhagavad Gita, Meditation, Yoga, Sanskrit, Chanting, Children's Classes, and Vedic Heritage School. | | Bischoff_Family_Archives Researching the line from Illingen, Wurttemberg, Germany. | | First_Nations_Commission_On_Civil_Rights Information concerning the civil rights of first nations people in the United States and Canada. | | An_Appeal_to_the_Young Essay by Peter Kropotkin, first published in 1880. | | The_Bank_Notes_of_Katanga Bills issued when the independence movement was active. | | Homesick Comprehensive site for Australians living abroad. | | The_Socialist_International Worldwide organization of major social democratic and labour parties. Site includes background, membership, resolutions, meeting reports, regular newsletter. | | Bob\'s_Book__Too_Young_To_Vote Eyewitness account of the South Pacific battles of Guadalcanal, Tarawa, Saipan and Tinian as seen through the eyes of Robert L. George. | | WW2_People\'s_War An opportunity for the war generation and their families to pass on their stories to future generations. | | Japanese_Animals\'_Temples_and_Shrines Pictures and stories of the Japanese most important animals, their shrines and temples: tanuki, kitsune, and inari. | | The_Flag_of_the_Passamaquoddy Picture and information about the tribal flag. | | Reformed_Quarterly The official publication of Reformed Theological Seminary, published four times a year. Full text of articles available. | | History_and_the_Philosophy_of_History George Burton Adams' presidential address to the American Historical Association in 1908. | | Canadian_Centre_for_Mine_Action_Technologies CCMAT works on research and development of low cost, sustainable technologies for mine detection, mine neutralization, personal protection and victim assistance. Provides news and resources. | | Gerstenberger,_Sonja_and_Scott Contains family blogs and photographs. | | Nancy_Ward Biography of the Cherokee tribal leader. | | Secrets_of_the_Heavens A Ficino-inspired musical setting of Renaissance Latin versions of several Orphic hymns. Background information on Ficino includes two papers by Angela Voss. |
|
Legal News Watch - Consumer Rights Blog
Home
Archives
About
Sitemap
RSS
Zyprexa Lawsuits: Lilly Agrees to Settle Most Claims
January 5th, 2007 · No Comments
Eli Lilly and Co. said on Thursday it has agreed to pay up to $500 million to settle 18,000 Zyprexa lawsuits alleging it had failed to adequately warn patients that Zyprexa may increase the risk of diabetes.“While we remain confident that these claims are without merit, we took this difficult step because we believe it is in the best interest of the company, the patients who depend on this medication, and their physicians,” said Sidney Taurel, chairman of the board and chief executive officer of Eli Lilly and Company. “We wanted to reduce significant uncertainties involved in litigating such complex cases. Our decision to resolve the claims does not change the fact that Zyprexa has and will continue to improve the lives of millions of patients around the world who are suffering from schizophrenia and bipolar disorder. These settlement agreements will enable Lilly to focus first and foremost on addressing unmet medical needs through research, educational programs and partnerships with doctors and patients.”In June 2005, Lilly agreed to pay about $700 million to settle 8,000 Zyprexa lawsuits in the United States.The majority of the of the Zyprexa lawsuits claim that before September 2003, the package insert warning about the potential link between Zyprexa and hyperglycemia and diabetes was not adequately displayed.In September 2003, the Food and Drug Administration required label changes for Zyprexa and all atypical antipsychotics, adding more information warning about a possible link with diabetes.In 2004, a panel of the American Diabetes Association found that Zyprexa caused diabetes more than other widely used antipsychotic drugs, in part becuase it has a tendency to cause more higher weight gain. However, the FDA has never made a similar finding.Share and Enjoy:These icons link to social bookmarking sites where readers can share and discover new web pages.          
→ No CommentsTags: Zyprexa
Legal News Watch: Top 10 Stories of 2006
December 31st, 2006 · No Comments
Which events in 2006 had the greatest impact on your legal rights? Below are our nominations for the top 10 stories of 2006:The Battle for Net Neutrality - CNETATT Collaborates with Illegal Domestic Spying Program - EFFU.S. Subpoena Power Used for Censorship - New York TimesU.S. Panel Rejects Plan for Paper Ballots - New York Times · No Comments
Pargluva, a proposed diabetes drug from Bristol-Myers Squibb and Merck & Company, appears to increase the risk of death, heart attack or stroke, according to a study published in a leading medical journal last week.The study was conducted by the two Cleveland Clinic cardiologists who warned in 2001 about the cardiovascular risks associated with Vioxx, which was pulled from the market last year. They used the data, from the company-funded clinical trials, that was submitted to the Food and Drug Administration.Their analysis found 1.47 percent of the diabetic patients who took Pargluva during clinical trials died, suffered a heart attack or stroke-more than double the rate among those taking a placebo or an already approved rival drug sold as Actos.James Brophy of McGill University in Montreal wrote an accompanying editorial for the study that was also published in The Journal of the American Medical Association, where he questions the “methodological decisions in the sponsor’s FDA application” that may foster an illusion of safety for Pargluva. He also included a list of 8 methods observed in the application that in his opinion may have contributed to an overestimate of the safety profile. (via The Journal of the American Medical Association)Share and Enjoy:These icons link to social bookmarking sites where readers can share and discover new web pages.
→ No CommentsTags: Pargluva
iPod Nano Lawsuit Filed Against Apple
October 26th, 2005 · 1 Comment
Jason Tomczak, an iPod Nano owner, has filed a lawsuit against Apple Computers, Inc. alleging the company launched the digital music player despite knowing that it was defective.The lawsuit, filed in the U.S. District Court in San Jose, California, claims that the iPod Nano scratches “excessively during normal usage,” rendering the screen on it unreadable, and charges Apple with violating state consumer protection statues, breach of express and implied warranties that accompanied the iPod Nano.Apple introduced the iPod Nano in September as a “revolutionary full-featured iPod yet thinner than a standard #2 pencil and less than half the size of competitive players.” However, the lawsuit claims the design of the iPod Nano is defective because it does not have sufficient resin to protect its face from extreme scratching and irreparable damage.Consumers “would not have purchased iPod Nanos or paid as much for them had they known the truth about the product,” the lawsuit contends.The suit is seeking class action status, restitution and disgorgement of profits, compensation for damages, punitive damages, attorneys’ fees and recovery of all costs associated with the suit. (via Reuters)Share and Enjoy:These icons link to social bookmarking sites where readers can share and discover new web pages.
→ 1 CommentTags: Apple
EA Agrees to Pay $15.6 Million to Settle Class Action on Overtime
October 17th, 2005 · No Comments
Electronic Arts has agreed to pay $15.6 million to settle a class action lawsuit brought by computer graphic artists seeking overtime compensation, the company announced on Oct. 5, 2005. The class includes computer graphic artists, including “animators,” “modelers,” “Texture artists,” “lighters,” “background effects artists,” “special effects artists” and “environmental artists,” who worked at EA’s California studios at any time from July 29, 2000 to the present.Under the terms of the settlement, the claims of the alleged class will be dismissed, and EA will make a total payment of $15.6 million to cover all claims by the class members, plaintiffs’ attorney fees, any incentive payments to the named plaintiffs and all administrative costs of the settlement. Any portion of the settlement fund that is unclaimed by class members will go to the Jackie Robinson Foundation, a national nonprofit organization that awards college scholarships to minority students, with a preference toward students interested in studying interactive entertainment.Settlement of the case, which is pending in the Superior Court of San Mateo County, California, must be approved by the Court before it can become effective.Electronic Arts (EA), headquartered in Redwood City, California, is the world’s leading interactive entertainment software company. Founded in 1982, the company develops, publishes, and distributes interactive software worldwide for videogame systems, personal computers and the Internet. (via Business Wire)Share and Enjoy:These icons link to social bookmarking sites where readers can share and discover new web pages.
→ No CommentsTags: Overtime
Paxil May Increase Risk of Birth Defects
October 4th, 2005 · No Comments
Paxil, an antidepressant drug, may increase the risk of birth defects for pregnant women taking it during the first trimester, the Food and Drug Administration warned last week.The warning comes after Paxil manufacturer GlaxoSmithKline sent the FDA and doctors a letter about preliminary results from a study suggest an increase in the risk of congenital malformations associated with the use of Paxil (paroxetine) as compared to other antidepressants.The types of congenital malformations, which were most commonly cardiovascular, were reflective of those seen in the general population. The most common cardiovascular malformations observed in the study were ventricular septal defects. Septal defects are sometimes called a “hole” in the heart. It is estimated that nearly 1 percent of babies are born with this condition. In the vast majority (80-90%) of babies born with this condition, the hole is small. They will have no symptoms, and the hole will close spontaneously as the muscular wall continues to grow after birth.Glaxo added that the preliminary results of this study and recent abstracts published by Alwan & Wogelius differ from previous epidemiologic studies, making it difficult to conclude whether a causal relationship exits.Healthcare professionals are advised to carefully weigh the potential risks and benefits of using Paxil therapy in women during pregnancy and to discuss these finding as well as treatment alternatives with their patients. (via U.S. Food and Drug Administration)Share and Enjoy:These icons link to social bookmarking sites where readers can share and discover new web pages.
→ No CommentsTags: Paxil
Strattera Linked to Suicidal Thinking in Children
October 4th, 2005 · 1 Comment
Strattera, an attention deficit hyperactivity disorder drug, may increase suicidal thinking in children and adolescents, the Food and Drug Administration warned on Thursday.“Children and adolescents being treated with Strattera should be closely monitored for clinical worsening, as well as agitation, irritability, suicidal thinking or behaviors, and unusual changes in behavior, especially during the initial few months of therapy or when the dose is changed (either increased or decreased),” the FDA said in a Public Health Advisory.The warning follows a review and analysis of clinical trials conducted in children with ADHD that identified an increased risk of suicidal thinking for Strattera. There was one suicide attempt by a patient who received Strattera among nearly 2,200 patients in the trial. The analysis showed that 0.4% of children treated with Strattera reported suicidal thinking compared to no cases in children treated with the placebo.Manufacturer Eli Lilly and Co. said last week it will add a “black box” warning to the Strattera label and is working with the FDA to finalize the product label content as well as information for healthcare professionals. Strattera is the only non-stimulant drug approved for the treatment of ADHD. It has been on the market since 2002 and has been used in more than two million patients. Sales for Strattera topped $667million last year. (via U.S. Food and Drug Administration)Share and Enjoy:These icons link to social bookmarking sites where readers can share and discover new web pages.
→ 1 CommentTags: Strattera
Class Action Filed Against Pfizer Over Marketing of Lipitor
September 28th, 2005 · 1 Comment
A nationwide class action lawsuit was filed today against Pfizer Inc., alleging the world’s largest drug company devised a promotional scheme to boost sales of its anti-cholesterol drug Lipitor by misleading women and seniors about the link between the drug and heart disease.The lawsuit, filed in the U.S. District Court in Boston, alleges that Pfizer engaged in a massive campaign to convince both doctors and patients that Lipitor is a beneficial treatment for nearly everyone with elevated cholesterol, even though no studies have shown it to be effective for women and those over 65 years of age who do not already have heart disease or diabetes.“We intend to prove that Pfizer pocketed billions in sales to those who do not benefit from Lipitor,” Steve Berman, the lead attorney for the proposed class, said.Lipitor, part of the class of drugs called statins, is the best-selling drug in the world, with sales in 2004 of more than $10 billion.According to the complaint, women without heart disease taking Lipitor actually developed 10 percent more heart attacks than women treated with a placebo.The proposed class action seeks to represent women who have taken Lipitor and who have no history of heart disease or diabetes; people aged 65 and over who have taken Lipitor and who have no history of heart disease or diabetes; and third-party payers such as insurance companies, union health and welfare funds, self-insured employers and others, who paid for Lipitor for patients in either of these two groups.The lawsuit alleges that Pfizer violated state consumer protection laws against deceptive advertising and seeks reimbursement for women and seniors and third-party payers who bought Lipitor unnecessarily as a result of Pfizer’s deceptive marketing and promotional campaign. “We intend to prove in this case that Pfizer’s false advertising created an enormous artificial demand for Lipitor, much of which would not exist if Pfizer had fully and fairly disclosed the truth about the drug,” Berman said. (via PR Newswire)Share and Enjoy:These icons link to social bookmarking sites where readers can share and discover new web pages.
→ 1 CommentTags: Lipitor
Class Action Lawsuit Filed Against Palm Over Treo 600 & Treo 650
September 25th, 2005 · 2 Comments
Three California consumers filed a class action lawsuit last week against Palm, Inc., accusing the company of selling defective Treo 600 and Treo 650 smartphones.The lawsuit, filed in the Superior Court of California for the County of Santa Clara, alleges that both devices suffer from numerous inherent defects that impair its functionality. These alleged problems include:� Extremely poor sound quality manifesting itself in a buzzing sound that is heard by the recipients of telephone calls made from the Treo 600,� Lost calls resulting from the Treo 600 spontaneously resetting itself in the middle of a phone conversation,� Frequent freezing and crashing in the Treo 650 that requires the use of a hard reset during which all stored information is lost.“We allege in our complaint that Palm has deliberately created a cycle of defective products whereby owners continue to receive defective phones until either they tire of the process or their warranty runs out,” Hector R. Martinez, attorney for the plaintiffs, said. “Each of the plaintiffs has attempted to have their phones replaced by Palm, instead of new phones they received what appear to be refurbished phones that had been returned to Palm by other customers — these replacement phones suffered from the same problems that were originally complained about.”This case was jointly filed by the Law Office of Mallison and Martinez and the Rothken Law Firm. (via Business Wire)Share and Enjoy:These icons link to social bookmarking sites where readers can share and discover new web pages.
→ 2 CommentsTags: Palm
← Previous Entries
Legal News Watch is a website about class action lawsuits, defective drugs, identity theft, unfair business practices and much more since 2002.
Recent Entries
Zyprexa Lawsuits: Lilly Agrees to Settle Most Claims1.5
Legal News Watch: Top 10 Stories of 200612.31
Just in time for New Years…12.28
Study Finds Pargluva May Increase Risk of Heart Attack or Stroke10.27
iPod Nano Lawsuit Filed Against Apple10.26
EA Agrees to Pay $15.6 Million to Settle Class Action on Overtime10.17
Paxil May Increase Risk of Birth Defects10.4
Strattera Linked to Suicidal Thinking in Children10.4
Class Action Filed Against Pfizer Over Marketing of Lipitor9.28
Class Action Lawsuit Filed Against Palm Over Treo 600 & Treo 6509.25
Categories
Abortion Abortion Pill (RU-486) Accutane Adderall Age Discrimination Antidepressants Antitrust Apple Asbestos and Mesothelioma Automobiles Avon Bait-and-Switch Baycol Bextra Botox Carbolith (Lithium Carbonate) Cash-Balance Pension Plans Celebrex Cell Phones Children's MOTRIN Cipro Clergy Abuse Clinical Trials Copyright Crestor Cylert Deceptive Advertising Deep Vein Thrombosis Defective Tires Dextromethorphan Diabetes Dietary Supplements Dioxin Exposure Discrimination DMCA Duragesic Effexor Employee Monitoring Employment and Labor EPA Ephedra ERISA Farmed Shrimp FDA Fen Phen Financial Financial Privacy Fraud Gefitinib Geodon Health Ibuprofen Identity Theft Insurance Industry Iressa IRS Junk Food Kickbacks Lariam Lead Paint Poisoning Legal News Watch Lipitor Mecury Medical Devices Medical Malpractice Medicare and Medicaid Fraud Meridia Miranda Rights Neurontin News Nexium Nursing Home Abuse Obesity Overtime OxyContin Palm Pargluva Paxil Paycheck-Cashing Fees Perchlorate Perfluorooctanoic Acid PFOA Phenylpropanolamine PPA Piracy Plavix polybrominated diphenyl ethers PBDEs polychlorinated biphenyl PCBs Predatory Lending Prescription Drugs Price-Fixing Privacy Propulsid Prozac Qui Tam Remeron Remicade Rezulin Risperdal Rollover Crashes Securities Fraud Serevent Seroquel Serzone Sex Discrimination Sexual Harassment Silica Strattera Teflon Thimerosal Tobacco Tobacoo Topamax Toxic Mold Uncategorized Unfair Business Practices US Patriot Act Viagra Vioxx Wage Abuse Welding Rod Wireless Industry Women's Rights Workplace Diversity Zocor Zoloft Zyprexa
© 2006 Legal News Watch - Consumer Rights Blog.
_uacct = "UA-96923-10";
urchinTracker();
|
|
